Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

Healthcare Medical Devices
MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

MedMira Inc
Bullboard Posts
User Avatar Image
(3)
•••
Post by DipsetKINGon Aug 15, 2017 10:15am
72 Views
Post# 26582399

maybe a reach but....

maybe a reach but....on the FDA page they updated the Medmira Establishment Profile yesterday......maybe some sort of development soon

Establishment: 
MedMira Laboratories Inc 
155 Chain Lake Drive 
Unit 1 
Halifax Nova Scotia,  CANADA  B3S 1B3 
Registration Number: 3003595936 
FEI Number*: 3003595936 
Status: Active 
Date Of Registration Status: 2017 

Owner/Operator: 
MEDMIRA LABORATORIES, INC. 
155 Chain Lake Dr. 
Suite 1 
Halifax,  CA-NS  CANADA  B3S 1B3 
Owner/Operator Number: 9039135 

Official Correspondent: 
Robyn Cook 
155 Chain Lake Dr. 
Suite 1 
Halifax,  CA-NS  CANADA  B3S 1B3 
Phone: 1-902-4501588 

US Agent: 
EJ Smith 
Smith Associates 
1468 Harwell Ave 
Crofton ,  MD  21114 
Phone: 410 4510639 Ext 
Fax: 410 7930448 
Email: Esmith9746@Aol.Com

Maybe that US agent can tell us something....Rizoletta i know how you like to dig this may help.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities